Status:

COMPLETED

Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine

Lead Sponsor:

University Hospital Muenster

Collaborating Sponsors:

Fresenius Kabi

IZKF (Interdisciplinary Centre for Clinical Research (IZKF), Muenster)

Conditions:

Cardiac Surgery

Acute Kidney Injury

Eligibility:

All Genders

18-90 years

Phase:

PHASE3

Brief Summary

The aim of this study is to evaluate whether the application of glutamine versus control in patients with high risk for AKI identified by biomarkers can reduce kidney damage after cardiac surgery.

Detailed Description

Cardiac surgery is characterized by an increased production of free radicals as a consequence of surgical trauma, ischemia-reperfusion injury, inflammatory response syndrome in response to the use of ...

Eligibility Criteria

Inclusion

  • Adult patients undergoing cardiac surgery with CPB
  • Urinary \[TIMP-2\]\*\[IGFBP7\] \>= 0.3 4h after CPB
  • Written informed consent

Exclusion

  • Preexisting AKI (stage 1 and higher)
  • Patients with cardiac assist devices
  • Pregnant women, nursing women and women of childbearing potential
  • Known (Glomerulo-) Nephritis, interstitial nephritis or vasculitis
  • Chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) \< 30 ml/min
  • Dialysis dependent CKD
  • Prior kidney transplant within the last to 12 months
  • Hypersensitivity to the active substance, or to any of the excipients of the study medication
  • Hepatic insufficiency
  • Severe metabolic acidosis (pH \< 7.2)
  • Participation in another intervention trial in the past 3 months
  • Persons with any kind of dependency on the investigator or employed by the institution responsible or investigator
  • Persons held in an institution by legal or official order

Key Trial Info

Start Date :

July 18 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 13 2020

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT04019184

Start Date

July 18 2019

End Date

May 13 2020

Last Update

May 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Münster

Münster, Germany, 48149